Evidence map›Paper›PMID 24493322›Full record

ArticleJournal of general internal medicine2014

Antihypertensive medication initiation among young adults with regular primary care use.

Heather M Johnson, Carolyn T Thorpe, Christie M Bartels, Jessica R Schumacher, Mari Palta, Nancy Pandhi, Ann M Sheehy, Maureen A Smith

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Heather M JohnsonDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA, hm2@medicine.wisc.edu.
Carolyn T Thorpe
Christie M Bartels
Jessica R Schumacher
Mari Palta
Nancy Pandhi
Ann M Sheehy
Maureen A Smith
University of Wisconsin–Madison · USUniversity of Pittsburgh · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Identifying and Addressing Barriers to Hypertension Control in Young AdultsK23HL112907 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JOHNSON, HEATHER M · 2012 to 2016
$845k
Continuity of Care and the Health of Older AdultsK08AG029527 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI PANDHI, NANCY · 2009 to 2013
$669k
Impact of Rheumatologist Communication Upon Managing Cardiovascular Risk in RAK23AR062381 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI BARTELS, CHRISTIE MICHELS · 2012 to 2015
$423k
NCATS NIH HHS U54TR000021NCATS NIH HHS UL1 TR000427NCRR NIH HHS UL1 RR025011NCRR NIH HHS UL1RR025011NHLBI NIH HHS K23 HL112907NHLBI NIH HHS K23HL112907NIAMS NIH HHS K23 AR062381NIAMS NIH HHS K23AR062381NIA NIH HHS K08 AG029527NIA NIH HHS K08AG029527
6 · The paper itself

Abstract

backgroundYoung adults with hypertension have the lowest prevalence of controlled blood pressure compared to middle-aged and older adults. Uncontrolled hypertension, even among young adults, increases future cardiovascular event risk. However, antihypertensive medication initiation is poorly understood among young adults and may be an important intervention point for this group.

objectiveThe purpose of this study was to compare rates and predictors of antihypertensive medication initiation between young adults and middle-aged and older adults with incident hypertension and regular primary care contact.

designA retrospective analysis

participantsAdults ≥ 18 years old (n = 10,022) with incident hypertension and no prior antihypertensive prescription, who received primary care at a large, Midwestern, academic practice from 2008-2011. MAIN MEASURES: The primary outcome was time from date of meeting hypertension criteria to antihypertensive medication initiation, or blood pressure normalization without medication. Kaplan-Meier analysis was used to estimate the probability of antihypertensive medication initiation over time. Cox proportional-hazard models (HR; 95% CI) were fit to identify predictors of delays in medication initiation, with a subsequent subpopulation analysis for young adults (18-39 years old). KEY

resultsAfter a mean follow-up of 20 (±13) months, 34% of 18-39 year-olds with hypertension met the endpoint, compared to 44% of 40-59 year-olds and 56% of ≥ 60 year-olds. Adjusting for patient and provider factors, 18-39 year-olds had a 44% slower rate of medication initiation (HR 0.56; 0.47-0.67) than ≥ 60 year-olds. Among young adults, males, patients with mild hypertension, and White patients had a slower rate of medication initiation. Young adults with Medicaid and more clinic visits had faster rates.

conclusionsEven with regular primary care contact and continued elevated blood pressure, young adults had slower rates of antihypertensive medication initiation than middle-aged and older adults. Interventions are needed to address multifactorial barriers contributing to poor hypertension control among young adults.

Indexed as

AdolescentAdultAntihypertensive AgentsBlood PressureFemaleFollow-Up StudiesHumansHypertensionMaleMiddle AgedPrimary Health CareRetrospective StudiesYoung AdultAntihypertensive Agents

Identifiers

PMID24493322
PMCPMC4000352
OpenAlexW2077693598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.